Showing results (321-330 of 426) with videos related to

Sort By:
Pageof 43
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1995
[Comparison of the effects of ketorolac and aspirin on hemostasis in the rabbit]C M Samama, M Daghfous, S Delaporte-Cerceau, et al.
Journal of Thrombosis and Haemostasis : JTH|June 27, 2006
A randomized study comparing the efficacy and safety of nadroparin 2850 IU (0.3 mL) vs. enoxaparin 4000 IU (40 mg) in the prevention of venous thromboembolism after colorectal surgery for cancerG Simonneau, S Laporte, P Mismetti, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasmaGrigoris T Gerotziafas, Ismail Elalamy, François Depasse, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|November 1, 1975
[Chronic pulmonary artery thrombosis. Therapeutic modality. Apropos of 6 cases]J Acar, C Cabrol, M Samama, et al.
Thrombosis Research|April 23, 2003
Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteersF Depasse, M J González de Suso, I Lagoutte, et al.
Chest|July 24, 2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jack Hirsh, Kenneth A Bauer, Maria B Donati, et al.
Annales Francaises D'Anesthesie Et De Reanimation|January 1, 1990
[Peri- and postoperative use of low molecular weight heparin in peripheral vascular surgery]C M Samama, S Mouren, M P Bridel, et al.
Thrombosis and Haemostasis|December 1, 1996
The antithrombotic potential of dalteparin in man assessed indirectly by Wessler's techniqueJ Millet, J Theveniaux, G Tachon, et al.
Seminars in Thrombosis and Hemostasis|April 1, 1987
Specific determination and identification of cross-linked fibrin degradation products in patients under thrombolytic therapy for myocardial infarctionJ Soria, C Soria, M Mirshahi, et al.
Pageof 43